Evidence map›Paper›PMID 42111542›Full record

ArticleJournal of clinical gynecology and obstetrics2026

Association Between Post-Trigger Hormones and

Olivia B Chafitz, Anat Chemerinski, Swata Gade, Evelyn Minis, Patricia Greenberg, Peter G McGovern, Sara S Morelli

Abstract read
In one paragraph

Article in Journal of clinical gynecology and obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Olivia B ChafitzDepartment of Obstetrics, Gynecology and Reproductive Health, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.ORCID 0000-0002-4211-6672
Anat ChemerinskiDepartment of Obstetrics, Gynecology and Reproductive Health, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.ORCID 0000-0002-8745-9409
Swata GadeDepartment of Obstetrics, Gynecology and Reproductive Health, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.ORCID 0009-0009-5085-8156
Evelyn MinisDepartment of Obstetrics, Gynecology and Reproductive Health, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
Patricia GreenbergDepartment of Biostatistics and Epidemiology, Rutgers School of Public Health, Rutgers University, Piscataway, NJ 08854, USA.ORCID 0000-0001-6652-5019
Peter G McGovernDepartment of Obstetrics, Gynecology and Reproductive Health, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.ORCID 0000-0002-1416-0764
Sara S MorelliDepartment of Obstetrics, Gynecology and Reproductive Health, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.ORCID 0000-0002-8894-465X

Funding

New Jersey Alliance for Clinical Translational Science: NJ ACTSUL1TR003017 · NCATS · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI PANETTIERI, REYNOLD ALEXANDER · 2019 to 2023
$28.9M
NCATS NIH HHS UL1 TR003017
6 · The paper itself

Abstract

Background: Numerous studies have evaluated the association between estradiol and progesterone levels on the day of trigger administration and cycle outcomes; however, less is known about serum hormone levels following trigger and whether they are associated with cycle outcomes. This study was conducted to assess the association between serum steroid hormone parameters on the day after oocyte maturation trigger and ovarian stimulation cycle outcomes. Methods: This was a retrospective cohort study. All patients undergoing ovarian stimulation with the use of gonadotropins between September 2018 and September 2020 were assessed for inclusion. Chart review was performed to collect demographic information, cycle and trigger type, pre- and post-treatment serum hormone levels (estradiol, progesterone), and cycle outcomes. The primary outcomes were oocyte recovery rate, oocyte maturity rate, oocyte fertilization rate, and blastulation rate. Results: A total of 320 cycles were included in the study from 245 unique patients; 19% of cycles utilized a gonadotropin-releasing hormone (GnRH) agonist stimulation protocol and 81% utilized a GnRH antagonist stimulation protocol. Post-trigger progesterone level was associated with poor oocyte recovery, but not with oocyte maturity, fertilization, or blastulation rates. Post-trigger estradiol levels were not associated with oocyte recovery rate, oocyte maturity rate, fertilization rate, or blastulation rate. Conclusions: This is one of few studies evaluating the association between estradiol and progesterone levels on the day after trigger injection and oocyte stimulation cycle outcomes. Our findings suggest that the association between post-trigger progesterone levels and poor oocyte recovery rate may be small but meaningful.

Indexed as

Assisted reproductive techniquesEstradiolInfertilityOvarian stimulationProgesterone

Identifiers

PMID42111542
PMCPMC13155448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.